A detailed history of Zacks Investment Management transactions in Illumina, Inc. stock. As of the latest transaction made, Zacks Investment Management holds 22,424 shares of ILMN stock, worth $3.05 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
22,424
Holding current value
$3.05 Million
% of portfolio
0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$105.28 - $135.9 $2.36 Million - $3.05 Million
22,424 New
22,424 $2.92 Million
Q4 2021

Feb 15, 2022

SELL
$347.28 - $421.83 $283,380 - $344,213
-816 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$405.61 - $524.84 $5.42 Million - $7.02 Million
-13,367 Reduced 94.25%
816 $331,000
Q2 2021

Aug 16, 2021

BUY
$372.84 - $481.5 $5.29 Million - $6.83 Million
14,183 New
14,183 $6.71 Million
Q3 2019

Nov 14, 2019

SELL
$266.84 - $378.23 $3.74 Million - $5.3 Million
-14,014 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$300.59 - $368.15 $138,571 - $169,717
461 Added 3.4%
14,014 $5.16 Million
Q1 2019

May 15, 2019

SELL
$272.57 - $321.18 $14,446 - $17,022
-53 Reduced 0.39%
13,553 $4.21 Million
Q4 2018

Feb 14, 2019

SELL
$272.46 - $366.54 $3.78 Million - $5.09 Million
-13,878 Reduced 50.49%
13,606 $4.08 Million
Q3 2018

Nov 14, 2018

SELL
$279.04 - $367.06 $46,041 - $60,564
-165 Reduced 0.6%
27,484 $10.1 Million
Q2 2018

Aug 14, 2018

BUY
$228.17 - $292.07 $1.49 Million - $1.91 Million
6,527 Added 30.9%
27,649 $7.72 Million
Q1 2018

May 14, 2018

BUY
$209.54 - $253.91 $169,517 - $205,413
809 Added 3.98%
21,122 $4.99 Million
Q4 2017

Feb 14, 2018

SELL
$202.23 - $230.03 $68,960 - $78,440
-341 Reduced 1.65%
20,313 $4.44 Million
Q3 2017

Nov 14, 2017

BUY
$172.3 - $213.93 $3.56 Million - $4.42 Million
20,654
20,654 $4.11 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.4B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Zacks Investment Management Portfolio

Follow Zacks Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Zacks Investment Management with notifications on news.